We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.5B
AUM Growth
+$2.42B
(+5.5%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
22.88%
Holding
1,939
New
86
Increased
673
Reduced
507
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$136M |
| 2 |
Bank of America
BAC
|
+$79.7M |
| 3 |
Goldman Sachs
GS
|
+$74.7M |
| 4 |
ConocoPhillips
COP
|
+$71.1M |
| 5 |
Visa
V
|
+$59.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$261M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$148M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$96.1M |
| 4 |
L3Harris
LHX
|
+$68.8M |
| 5 |
Royal Bank of Canada
RY
|
+$61.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.7% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 14.79% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
vTv Therapeutics
VTVT
$122M
| $909K | ﹤0.01% |
8,057
+3,354
| +71% | +$330K |
|
1452
Deutsche Bank
DB
$67.6B
| $906K | ﹤0.01% |
72,650
| – | – |
|
1453
QuinStreet
QNST
$916M
| $903K | ﹤0.01% |
44,500
| – | – |
|
1454
Vipshop
VIPS
$7.13B
| $903K | ﹤0.01% |
30,250
+22,250
| +278% | +$767K |
|
1455
Caleres
CAL
$447M
| $900K | ﹤0.01% |
41,300
+3,200
| +8% | +$54.5K |
|
1456
Columbia Sportswear
COLM
$3.3B
| $898K | ﹤0.01% |
8,500
+700
| +9% | +$69.3K |
|
1457
REX American Resources
REX
$1.4B
| $896K | ﹤0.01% |
63,906
| – | – |
|
|
VIVO
1458
DELISTED
Meridian Bioscience Inc
VIVO
| $895K | ﹤0.01% |
34,100
+20,200
| +145% | +$480K |
|
1459
Chegg
CHGG
$121M
| $891K | ﹤0.01% |
10,400
+896
| +9% | +$85.4K |
|
1460
Bilibili
BILI
$7.56B
| $889K | ﹤0.01% |
8,300
+6,100
| +277% | +$745K |
|
|
NXGN
1461
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $888K | ﹤0.01% |
49,084
| – | – |
|
1462
PetMed Express
PETS
$43M
| $887K | ﹤0.01% |
25,217
| – | – |
|
1463
PTC Therapeutics
PTCT
$6.25B
| $879K | ﹤0.01% |
18,568
-36,757
| -66% | -$2.18M |
|
1464
Shattuck Labs
STTK
$651M
| $877K | ﹤0.01% |
30,000
| – | – |
|
1465
Genesco
GCO
$432M
| $875K | ﹤0.01% |
18,431
| – | – |
|
|
SJR
1466
DELISTED
Shaw Communications Inc.
SJR
| $874K | ﹤0.01% |
34,057
| – | – |
|
1467
Rhythm Pharmaceuticals
RYTM
$7.41B
| $870K | ﹤0.01% |
40,891
+19,718
| +93% | +$572K |
|
1468
IDEAYA Biosciences
IDYA
$3.48B
| $868K | ﹤0.01% |
36,915
| – | – |
|
1469
Zumiez
ZUMZ
$347M
| $867K | ﹤0.01% |
20,200
| – | – |
|
1470
Innoviva
INVA
$1.61B
| $866K | ﹤0.01% |
72,501
+9,800
| +16% | +$119K |
|
1471
Protagonist Therapeutics
PTGX
$8.8B
| $861K | ﹤0.01% |
33,230
| – | – |
|
1472
Frontdoor
FTDR
$5.22B
| $859K | ﹤0.01% |
15,975
-21,152
| -57% | -$1.15M |
|
1473
Envista
NVST
$4.39B
| $855K | ﹤0.01% |
20,965
-13,022
| -38% | -$496K |
|
1474
Zymeworks
ZYME
$1.66B
| $849K | ﹤0.01% |
26,892
+9,191
| +52% | +$374K |
|
1475
GoDaddy
GDDY
$13.6B
| $848K | ﹤0.01% |
10,925
-9,523
| -47% | -$766K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Ensign Peak Advisors held 1,939 positions worth $46.5B, up 5.5% from $44.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ensign Peak Advisors's Q1 2021 filing shows 86 new, 673 increased, 507 reduced and 115 closed positions. Its largest new stake was State Street Blackstone Senior Loan ETF: 1,200,000 shares worth $54.9M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $261M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2021 buy was State Street Blackstone Senior Loan ETF: 1,200,000 shares worth $54.9M.
- Ensign Peak Advisors added most to Tesla in Q1 2021, an estimated $136M increase.
- Ensign Peak Advisors's biggest Q1 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $96.1M.
- Ensign Peak Advisors fully exited iShares Core MSCI Emerging Markets ETF in Q1 2021, selling an estimated $261M.
- Ensign Peak Advisors's ten largest holdings make up 23% of its $46.5B portfolio in Q1 2021.
- Ensign Peak Advisors opened 86 new positions and closed 115 in Q1 2021.
- Ensign Peak Advisors's portfolio value rose 5.5% quarter-over-quarter to $46.5B.
Based on Ensign Peak Advisors's 13F filing for Q1 2021, filed 12 May 2021.